A first-in-human trial of GLS4, a novel inhibitor of hepatitis B virus capsid assembly, following single- and multiple-ascending oral dose studies with or without ritonavir in healthy adult volunteers
Zhao, Nan, Jia, Bo, Zhao, Hong, Xu, Junyu, Sheng, Xiaoyan, Luo, Lin, Huang, Zhangma, Wang, Xingan, Ren, Qingyun, Zhang, Yingjun, Zhao, Xia, Cui, YiminLanguage:
english
Journal:
Antimicrobial Agents and Chemotherapy
DOI:
10.1128/AAC.01686-19
Date:
October, 2019
File:
PDF, 1.26 MB
english, 2019